FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2320236424> ?p ?o ?g. }

• W2320236424 abstract "Surgery and radiation can cure localized prostate cancer, but not metastatic disease. Our research has shown that activated Δ5α1 integrin fibronectin receptors mediate metastatic invasion by human prostate cancer cell lines, DU 145 and PC-3, as well as angiogenic invasion by human microvascular endothelial cells (hmvec). Thus, activated Δ5α1 receptors are key to metastatic progression. To inhibit metastatic invasion, we devised the Ac-PHSCN-NH2 peptide, PHSCN, licensed as ATN-161. Systemic ATN-161 monotherapy was well tolerated in Phase I trial, and halted metastatic progression for 4-14 months in 35% of patients; however, it was not potent enough for easy administration. Thus, there are some major difficulties with ATN-161 as a drug. Also, PHSCN can be degraded by endoproteinases, enzymes that cleave between its linked L-amino acids. Since tumors secrete abundant endoproteinases, we devised a potent, exo- and endoproteinase-resistant, Δ5α1αtargeted invasion inhibitor, the Ac-PhScN-NH2 peptide (PhScN). Because it contains mirror image D-isomers of His (h) and Cys (c) separating L-isomers of Pro, Ser, and Asn, is resistant to endoproteolytic degradation. Our results suggest that PhScN is 27,000 to 340,000-fold more potent than PHSCN at blocking Δ5α1-mediated, serum-induced, or serum-free PHSRN peptide-induced invasion in vitro by metastatic human DU 145 and PC-3 prostate cancer cells. Our results also indicate that a single pretreatment of suspended DU 145 and PC-3 cells with varying concentrations of the PhScN peptide prior to intravenous injection reduces lung colony formation in athymic, nude mice by 100,000 to 300,000-fold, relative to lung metastasis inhibition by the parental PHSCN peptide. Because Δ5α1 integrin also supports survival, we determined the effects of elevated PhScN concentrations on clonogenic DU 145 and PC-3 survival in vitro. We found that PhScN has no appreciable effect on clonogenic survival, suggesting that its potent anti-metastatic activity is due to invasion inhibition in lung microvasculature. Consistent with this hypothesis, our preliminary results suggest that PhScN pretreatment is also significantly more potent method for preventing extravasation into lung tissue than pretreatment with the parental PHSCN peptide. Since our published results show that the PHSCN polylysine dendrimer (PHSCNGGK-MAP) is 100-fold more potent than the PHSCN peptide at inhibiting DU 145 and PC-3 lung colonization, the results presented here suggest that D-amino acid substitution in the PHSCN sequence, thereby forming the PhScN peptide or dendrimer (PhScNGGK-MAP) may be an excellent strategy for the synthesis of highly potent Δ5α1-targeted inhibitors of metastatic invasion and lung colonization. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3890. doi:1538-7445.AM2012-3890" @default.
• W2320236424 created "2016-06-24" @default.
• W2320236424 creator A5017776842 @default.
• W2320236424 creator A5040173084 @default.
• W2320236424 creator A5075183062 @default.
• W2320236424 creator A5090369014 @default.
• W2320236424 date "2012-04-15" @default.
• W2320236424 modified "2023-09-27" @default.
• W2320236424 title "Abstract 3890: The PhScN peptide as a highly potent inhibitor of basement membrane invasion in vitro and lung colonization in nude mice by metastatic human prostate cancer cells" @default.
• W2320236424 doi "https://doi.org/10.1158/1538-7445.am2012-3890" @default.
• W2320236424 hasPublicationYear "2012" @default.
• W2320236424 type Work @default.
• W2320236424 sameAs 2320236424 @default.
• W2320236424 citedByCount "0" @default.
• W2320236424 crossrefType "proceedings-article" @default.
• W2320236424 hasAuthorship W2320236424A5017776842 @default.
• W2320236424 hasAuthorship W2320236424A5040173084 @default.
• W2320236424 hasAuthorship W2320236424A5075183062 @default.
• W2320236424 hasAuthorship W2320236424A5090369014 @default.
• W2320236424 hasConcept C121608353 @default.
• W2320236424 hasConcept C126322002 @default.
• W2320236424 hasConcept C1491633281 @default.
• W2320236424 hasConcept C170493617 @default.
• W2320236424 hasConcept C202751555 @default.
• W2320236424 hasConcept C2779013556 @default.
• W2320236424 hasConcept C2779281246 @default.
• W2320236424 hasConcept C2780192828 @default.
• W2320236424 hasConcept C502942594 @default.
• W2320236424 hasConcept C55493867 @default.
• W2320236424 hasConcept C71924100 @default.
• W2320236424 hasConcept C86492073 @default.
• W2320236424 hasConcept C86803240 @default.
• W2320236424 hasConcept C96232424 @default.
• W2320236424 hasConcept C98274493 @default.
• W2320236424 hasConceptScore W2320236424C121608353 @default.
• W2320236424 hasConceptScore W2320236424C126322002 @default.
• W2320236424 hasConceptScore W2320236424C1491633281 @default.
• W2320236424 hasConceptScore W2320236424C170493617 @default.
• W2320236424 hasConceptScore W2320236424C202751555 @default.
• W2320236424 hasConceptScore W2320236424C2779013556 @default.
• W2320236424 hasConceptScore W2320236424C2779281246 @default.
• W2320236424 hasConceptScore W2320236424C2780192828 @default.
• W2320236424 hasConceptScore W2320236424C502942594 @default.
• W2320236424 hasConceptScore W2320236424C55493867 @default.
• W2320236424 hasConceptScore W2320236424C71924100 @default.
• W2320236424 hasConceptScore W2320236424C86492073 @default.
• W2320236424 hasConceptScore W2320236424C86803240 @default.
• W2320236424 hasConceptScore W2320236424C96232424 @default.
• W2320236424 hasConceptScore W2320236424C98274493 @default.
• W2320236424 hasLocation W23202364241 @default.
• W2320236424 hasOpenAccess W2320236424 @default.
• W2320236424 hasPrimaryLocation W23202364241 @default.
• W2320236424 hasRelatedWork W10860069 @default.
• W2320236424 hasRelatedWork W11138111 @default.
• W2320236424 hasRelatedWork W4242833 @default.
• W2320236424 hasRelatedWork W6042099 @default.
• W2320236424 hasRelatedWork W7465862 @default.
• W2320236424 hasRelatedWork W7506178 @default.
• W2320236424 hasRelatedWork W8114580 @default.
• W2320236424 hasRelatedWork W8802154 @default.
• W2320236424 hasRelatedWork W9592702 @default.
• W2320236424 hasRelatedWork W7109828 @default.
• W2320236424 isParatext "false" @default.
• W2320236424 isRetracted "false" @default.
• W2320236424 magId "2320236424" @default.
• W2320236424 workType "article" @default.